財務情報
- Market Capitalization 242.46 M
- Employee 533
- Founded 2002
- CEO N/A
- Website www.vandapharma.com
- Headquarter Delaware, United States
- FIGI BBG000HT5MG6
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-2.36
売上高対価格比率
2.41
関連ティッカー
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3367 | FATE Fate Therapeutics, Inc. - Common Stock | 2.08 USD | +0.97% | +7.22% | -18.43% | +35.95% | 249.23 M USD | ||
| 3374 | RCKT Rocket Pharmaceuticals, Inc. - Common Stock | 2.20 USD | -5.98% | -0.45% | -33.13% | -44.58% | 241.50 M USD | ||
| 3382 | IMRX Immuneering Corporation - Class A Common Stock | 3.75 USD | +0.54% | +9.65% | -16.67% | -35.12% | 242.62 M USD | ||
| 3384 | PALI Palisade Bio, Inc. - Common Stock | 1.40 USD | -2.10% | -6.67% | -18.13% | -17.65% | 243.98 M USD |